(July 11, 2023, 11:50 AM EDT) -- WASHINGTON, D.C. — The Patent Trial and Appeal Board wrongly rejecting in full an inter partes review (IPR) petitioner’s claim that two Medtronic Inc. neurostimulation patents are obvious, the Federal Circuit U.S. Court of Appeals ruled July 10....